Literature DB >> 1341260

K-ras gene mutation in colorectal adenomas and carcinomas from familial adenomatous polyposis patients.

I S Boughdady1, A R Kinsella, N Y Haboubi, P F Schofield.   

Abstract

Colorectal adenomas and carcinomas from familial adenomatous polyposis (FAP) patients were screened for the presence of K-ras gene mutations at codon 12 using an in vitro amplification step (polymerase chain reaction) followed by dot blot analysis using oligonucleotide probes specific for different mutations at codon 12. We examined 28 colorectal adenomas and two colorectal carcinomas from 12 FAP patients and observed a mutation at codon 12 in seven adenomas and in both carcinomas. The frequency of K-ras gene mutations in colorectal tumours from FAP patients is similar to those in cases of sporadic adenomas and sporadic colorectal carcinomas indicating that the mechanisms involved in their development may be similar.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341260     DOI: 10.1016/0960-7404(92)90087-2

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  2 in total

Review 1.  Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

Authors:  Tomoya Yokota
Journal:  Anticancer Agents Med Chem       Date:  2012-02       Impact factor: 2.505

Review 2.  Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review.

Authors:  Yuan-Yi Rui; Dan Zhang; Zong-Guang Zhou; Cun Wang; Lie Yang; Yong-Yang Yu; Hai-Ning Chen
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.